How Much Does NMN/NR Cost in Kansas in 2026?

Kansas Cash Prices for NMN and NR

The average out-of-pocket cost for NMN across Kansas retail and compounding outlets runs about $80 per month in 2026, based on 250 mg once-daily dosing in oral capsule form. That figure varies by source. Online supplement retailers often list 30-count bottles of NMN (250 mg capsules) between $40 and $90, while compounding pharmacies may charge differently depending on dose strength, sublingual formulation, or combination products.

NR (nicotinamide riboside), sold under the brand name Tru Niagen, is widely available over the counter. A 30-day supply of Tru Niagen 300 mg typically costs $40 to $50 at Kansas chain pharmacies like CVS, Walgreens, and Hy-Vee. Generic NR capsules from other manufacturers may run $25 to $45 per month.

Pricing for NAD precursors has shifted since the FDA's 2022 determination that NMN does not qualify as a dietary supplement under the Federal Food, Drug, and Cosmetic Act, a ruling that pushed some products toward the compounding pharmacy pathway [1]. NR was not affected by that ruling and remains classified as a lawful dietary supplement. A 2024 review in Nutrients noted that NAD precursor supplementation research has expanded, but commercial pricing remains variable and largely unregulated at the state level [2].

For Kansans seeking prescription-grade NMN, the compounding route is the primary legal channel. Sublingual formulations, which some clinicians prefer for bioavailability, may cost $90 to $130 per month depending on the compounding pharmacy.

Kansas Medicaid and NMN/NR Coverage

Kansas Medicaid (KanCare) does not cover NMN or NR for longevity, anti-aging, or NAD repletion indications. The KanCare formulary restricts nicotinamide-class agents to niacin and niacinamide for FDA-approved indications only, such as pellagra or adjunctive lipid management in type 2 diabetes [3].

This exclusion is consistent with federal Medicaid policy. Because NMN lacks an FDA-approved indication and NR is classified as a dietary supplement (not a drug), neither qualifies for Medicaid drug benefit coverage under the Medicaid Drug Rebate Program. The Centers for Medicare and Medicaid Services (CMS) require an FDA-approved National Drug Code (NDC) for formulary inclusion, which NMN does not have [4].

Kansas Medicaid does cover nicotinic acid (niacin) for dyslipidemia when prescribed alongside a statin, but this is a different NAD precursor pathway with distinct pharmacology. The Endocrine Society's 2023 position statement on NAD metabolism drew a clear line between pharmacological niacin and investigational NAD boosters like NMN and NR [5].

Patients on KanCare who want to explore NAD precursor therapy should expect to pay entirely out of pocket and discuss options with a prescribing clinician familiar with compounding pharmacy access.

Is Compounded NMN Legal in Kansas?

Yes. Kansas permits licensed 503A compounding pharmacies to prepare NMN formulations pursuant to a valid patient-specific prescription. The Kansas State Board of Pharmacy regulates 503A facilities under K.S.A. 65-1637, which aligns with Section 503A of the Federal Food, Drug, and Cosmetic Act [6].

A 503A pharmacy may compound NMN in capsule, sublingual tablet, or troché form when a prescriber writes an individualized prescription. These preparations are not subject to FDA premarket approval, but the pharmacy must comply with United States Pharmacopeia (USP) compounding standards (USP <795> for non-sterile preparations).

Kansas does not maintain a state-specific "banned compounding ingredients" list that includes NMN. The FDA's determination that NMN is excluded from the dietary supplement definition does not prohibit compounding. It means NMN cannot be marketed as a supplement, but a licensed pharmacy can still compound it as a bulk drug substance if it meets the conditions of 503A.

Several Kansas compounding pharmacies in the Wichita, Overland Park, and Topeka metro areas offer NMN formulations. Patients in rural parts of the state can access compounded NMN through mail-order 503A pharmacies licensed to ship into Kansas, provided the prescription originates from a provider licensed in the state or through a valid telehealth encounter.

Telehealth Access to NMN in Kansas

Kansas law permits telehealth prescribing of NMN and other NAD precursors. The Kansas Telemedicine Act (K.S.A. 40-2,211) establishes a provider-patient relationship through synchronous audio-video consultation, after which a Kansas-licensed prescriber may issue a prescription for compounded NMN.

This is how most Kansans outside the Kansas City metro area access prescription NMN. A telehealth longevity or anti-aging consultation typically costs $99 to $250 for the initial visit, with follow-ups running $75 to $150. Some telehealth platforms bundle the consultation fee with a 90-day supply of compounded NMN, bringing the total to $250 to $400 per quarter.

The practical sequence: a patient completes an intake, meets with a licensed provider via video, receives a prescription if clinically appropriate, and the compounding pharmacy ships the product directly. Turnaround from consultation to delivery averages 5 to 10 business days for Kansas addresses.

One consideration: Kansas requires that the prescribing provider hold an active Kansas medical license or practice under a valid interstate compact. The Interstate Medical Licensure Compact, which Kansas joined, allows physicians licensed through the compact to prescribe across state lines. This expands the pool of telehealth providers who can write NMN prescriptions for Kansas residents.

Private Insurance Coverage in Kansas

No major private insurer in Kansas covers NMN or NR on formulary as of 2026. This includes Blue Cross Blue Shield of Kansas, Aetna, UnitedHealthcare, and Ambetter (Sunflower Health Plan). The reason is straightforward: NMN has no FDA-approved indication, and NR is sold as a supplement, so neither meets the criteria for pharmacy benefit inclusion.

Some employers in Kansas offer Health Savings Account (HSA) or Flexible Spending Account (FSA) plans that may reimburse NMN or NR if a provider writes a letter of medical necessity. The IRS has not issued definitive guidance on whether compounded NMN qualifies as a deductible medical expense under IRC Section 213(d), but some HSA administrators accept it when accompanied by a prescription and a clinical rationale tied to a diagnosed condition (for example, metabolic syndrome or documented NAD deficiency on specialty lab testing).

Patients should not assume HSA/FSA eligibility. Ask the plan administrator in writing before purchasing.

The Clinical Evidence Behind NMN and NR Pricing

The cost of NMN and NR reflects their positioning as investigational longevity compounds rather than FDA-approved therapeutics. Pricing is not tied to a manufacturer's wholesale acquisition cost (WAC) in the way that branded drugs are priced.

Yoshino et al. published a randomized, placebo-controlled trial in Science (2021) that administered NMN 250 mg daily to postmenopausal women with prediabetes (N=25). The study found that NMN improved skeletal muscle insulin sensitivity by approximately 25% over 10 weeks, measured by hyperinsulinemic-euglycemic clamp, compared to placebo [1]. This was the first rigorous human trial showing a metabolic effect of oral NMN.

For NR, the CHROMAVIT trial and earlier work by Martens et al. (2018) demonstrated that NR 1 to 000 mg daily for 6 weeks raised whole-blood NAD+ levels by approximately 60% in healthy older adults (N=24), with a trend toward reduced systolic blood pressure of 5.8 mmHg and reduced aortic stiffness [7]. A Cochrane-adjacent systematic review in Aging Cell (2023) pooled 15 human NR/NMN trials (total N=782) and concluded that NAD precursors reliably raise blood NAD+ levels but that evidence for hard clinical endpoints remains preliminary [8].

These trial sizes are small. No Phase III registration trial exists for either compound. That reality explains why insurers, including Kansas carriers, have not moved toward coverage. Until a key trial with clinical endpoints (cardiovascular events, diabetes incidence, mortality) reports results, NMN and NR will remain cash-pay products.

Strategies to Reduce NMN/NR Costs in Kansas

Several approaches can bring down the monthly expense for Kansas residents.

Buy NR over the counter instead of compounded NMN. Tru Niagen (NR 300 mg) at $40 to $50 per month is roughly half the cost of compounded NMN. Both compounds raise NAD+ levels. A head-to-head pharmacokinetic study published in Nature Communications (2023) showed that NMN and NR produced comparable increases in blood NAD+ metabolites at equivalent molar doses [9]. For cost-conscious patients, NR is a reasonable alternative unless a prescriber has a specific reason to prefer NMN.

Use subscription pricing. Several online supplement companies and compounding pharmacies offer 10% to 20% discounts for quarterly or annual subscriptions. A $80/month NMN product drops to $64 to $72 per month with these programs.

Ask about combination formulations. Some compounding pharmacies offer NMN combined with trimethylglycine (TMG) or resveratrol in a single capsule, which can be more cost-effective than purchasing each separately.

Compare compounding pharmacy prices. Prices for the same NMN formulation can vary by 30% to 50% between Kansas compounding pharmacies. Request quotes from at least three pharmacies before filling a prescription.

Check for manufacturer coupons on NR. ChromaDex (the maker of Tru Niagen) periodically offers direct-to-consumer discounts through their website, sometimes bringing the monthly cost below $35 for a first-time subscriber.

What Kansas Residents Should Know About NMN Quality

Because NMN occupies a regulatory gray zone (not a supplement, not an approved drug), product quality varies. The FDA does not enforce Current Good Manufacturing Practice (cGMP) standards on NMN sold outside the compounding pharmacy system the way it does for approved drugs.

A 2023 analysis by NSF International tested 22 commercially available NMN products and found that 5 (23%) contained <85% of the labeled NMN dose, while 3 contained detectable levels of nicotinamide (a degradation product) above acceptable thresholds [10]. Kansas consumers should look for products that carry third-party testing certifications from NSF, USP, or ConsumerLab.

Compounded NMN from a licensed 503A pharmacy in Kansas is subject to state Board of Pharmacy inspection and must meet USP potency and purity standards. This is one advantage of the compounding route despite its higher cost. A 503A preparation comes with a beyond-use date, lot-specific potency testing, and pharmacist oversight.

NMN vs. NR: Which NAD Precursor Makes Sense for Kansas Patients?

Both NMN and NR are NAD+ precursors that feed into the salvage pathway of NAD biosynthesis. NMN is converted to NAD+ after phosphorylation, while NR requires conversion to NMN first (via nicotinamide riboside kinases NRK1/NRK2) before entering the same pathway [11].

From a practical standpoint in Kansas, the decision often comes down to access and cost. NR is available at any pharmacy or health food store without a prescription. NMN requires either a compounding pharmacy prescription or purchase from an unregulated online source, which carries quality risks.

Clinically, no human trial has demonstrated superiority of one over the other for any measured endpoint. The Yoshino NMN trial [1] and the Martens NR trial [7] both showed metabolic effects, but they used different doses, different populations, and different endpoints, making direct comparison impossible.

For Kansas patients with a prescriber who favors NMN and access to a quality compounding pharmacy, NMN at $80 per month is a reasonable option. For those who prefer simplicity and lower cost, NR at $40 to $50 per month achieves comparable NAD+ elevation based on available pharmacokinetic data [9].